Search Results
Dec 12, 2025, 16:38 ET Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL
Avadel Pharmaceuticals plc (NasdaqGM: AVDL) to Alkermes plc (NasdaqGS: ALKS). Under the terms of the proposed transaction, shareholders of Avadel will receive $18.50 per share, plus a non-transferable
More news about: Kahn Swick & Foti, LLC
Nov 19, 2025, 18:15 ET Halper Sadeh LLC Encourages SEMR, AVDL, CADE, DENN Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-semr-avdl-cade-denn-shareholders-to-contact-the-firm-to-discuss-their-rights-302620946.html
More news about: Halper Sadeh LLP
Nov 19, 2025, 14:10 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-DENN, ELST, AVDL, and CADE
AVDL ) related to its sale to Alkermes plc. Under the terms of the proposed transaction, Avadel shareholders
More news about: Monteverde & Associates PC
Nov 19, 2025, 06:00 ET Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
Nov. 19, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have reached agreement on the terms of an increased recommended offer under which Alkermes will
More news about: Alkermes plc
Nov 13, 2025, 17:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE
AVDL) related to its sale to Alkermes plc. Under the terms of the proposed transaction, Avadel shareholders will receive $18.50 per share, plus a non-transferable
More news about: Monteverde & Associates PC
Oct 22, 2025, 17:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
AVDL) related to its sale to Alkermes plc. Under the terms of the proposed transaction, Avadel shareholders will receive $18.50 per share, plus a non-transferable
More news about: Monteverde & Associates PC
Oct 22, 2025, 15:45 ET HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-avdl-mbcn-fmnb-shareholders-to-enforce-their-rights-and-contact-the-law-firm-302591523.html
More news about: Halper Sadeh LLP
Oct 22, 2025, 07:00 ET Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will acquire Avadel, a commercial-stage
More news about: Alkermes plc; Avadel Pharmaceuticals plc